Dataset Information


Treatment of uveal melanoma: where are we now?

ABSTRACT: Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop metastatic disease. Outcomes for those with metastatic disease remain dismal due to a lack of effective therapies. The unique biology and immunology of uveal melanoma necessitates the development of dedicated management and treatment approaches. Ongoing efforts seek to optimize the efficacy of targeted therapy and immunotherapy in both the adjuvant and metastatic setting. This review provides a comprehensive, updated overview of disease biology and risk stratification, the management of primary disease, options for adjuvant therapy, and the current status of treatment strategies for metastatic disease.


PROVIDER: S-EPMC5824910 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4864524 | BioStudies
2019-01-01 | S-EPMC6406862 | BioStudies
2017-01-01 | S-EPMC5298817 | BioStudies
2019-01-01 | S-EPMC6562554 | BioStudies
2015-01-01 | S-EPMC4326637 | BioStudies
2020-01-01 | S-EPMC7600598 | BioStudies
1000-01-01 | S-EPMC5076295 | BioStudies
2017-01-01 | S-EPMC5256122 | BioStudies
2020-01-01 | S-EPMC7171146 | BioStudies
2012-01-01 | S-EPMC3935729 | BioStudies